🇺🇸 FDA
Patent

US 11351276

Radiopharmaceutical compositions of radioactive halogenated benzylguanidine

granted A61KA61K47/10A61K47/12

Quick answer

US patent 11351276 (Radiopharmaceutical compositions of radioactive halogenated benzylguanidine) held by Jubilant Draximage Inc. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jubilant Draximage Inc.
Grant date
Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K47/10, A61K47/12, A61K47/22, A61K51/04